BioPharma Credit PLC (LON:BPCR)

BioPharma Credit Revenue

In the year 2025, BioPharma Credit had annual revenue of $157.78M USD with 5.17% growth. BioPharma Credit had revenue of $73.98M in the half year ending December 31, 2025, with 29.30% growth.

• Revenue: $157.78M
• Revenue Growth: +5.17%
• P/S Ratio: 6.95
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 814.19M GBP

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	157.78M	7.76M	5.17%
Dec 31, 2024	150.03M	14.30M	10.53%
Dec 31, 2023	135.73M	-82.41M	-37.78%
Dec 31, 2022	218.14M	114.28M	110.03%
Dec 31, 2021	103.86M	-6.15M	-5.59%
Dec 31, 2020	110.01M	-40.89M	-27.10%
Dec 31, 2019	150.89M	53.61M	55.11%
Dec 31, 2018	97.28M	-	-

Data Source: Fiscal.ai Last updated: Feb 14, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 26, 2026

Data Sources Report a data error